Detalhe da pesquisa
1.
Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis.
Pediatr Allergy Immunol
; 34(7): e13982, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37492920
2.
Urticaria and angioedema in children and adolescents: diagnostic challenge.
Allergol Immunopathol (Madr)
; 50(S Pt 1): 17-29, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35726487